Modulaton of alpha-6 integrin-mediated responses
CA 2409868 A1 · Owner: Clagett, James · Inventors: Palmer, Craig; Clagett, James; Lipani, John
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for modulating an alpha 6 subunit containing integrin-mediated signal transduction is described. The method involves contacting a cell with an effective integrin modulating amount of an alpha 6 subunit containing integrinmediated signal transduction pathway modification agent. Preferred agents are peptides having the formula f-Met-Leu-X wherein X is selected from the group , consisting of Tyr Tyr-Phe, Phe-Phe and Phe-Tyr.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 23, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 23, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 23, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.